Alunacedase alfa Completed Phase 2 Trials for Pulmonary Hypertension (PH) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03177603A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)